Navigation Links
Medical researchers make important research link between active ingredient in saffron and MS

Medical researchers at the University of Alberta have discovered that an active ingredient in the Persian spice saffron may be a potential treatment for diseases involving neuroinflammation, such as multiple sclerosis.

Chris Power and a team of researchers in the Faculty of Medicine & Dentistry recently published their findings in the peer-reviewed publication, The Journal of Immunology.

"We found there is a compound in saffron, known as crocin, that exerts a protective effect in brain cell cultures and other models of MS. It prevented damage to cells that make myelin in the brain," Power said. "Myelin is insulation around nerves. MS is characterized by inflamed brain cells that have lost this protective insulation, which ultimately leads to neurodegeneration."

Power noted they are not close to a clinical trial stage yet, but the finding is still exciting.

It has been known in the research community for years that crocin protected neurons in certain situations, but Power and his team wanted to delve further into this area.

His team discovered that inflammation and a specific type of cell stress are closely linked and lead to neurodegeneration and inflammation which cause cells to lose their protective coating a process known as demyelination. In experiments conducted by Power and his colleagues, the use of crocin suppressed both inflammation and this specific type of cell stress, resulting in decreased neurological impairment in lab models and cell cultures with MS.

"There are still many questions to be answered about how crocin exerts these neuroprotective effects, but this research highlights a potential treatment role for crocin in diseases involving chronic neuroinflammation something that had not been recognized until now," says Power.

He explained the research demonstrates a new mechanism in MS, provides new potential drug targets in the future, and helps explain why physicians see inflammation in MS.

The team's research also revealed that this specific type of cell stress, called the unfolded protein response, may be caused by an ancient virus that was introduced into the DNA of early humans. This particular cell stress is found at high levels in MS brain lesions.

"We all have this ancient virus in our DNA, but for some reason it is excessively turned on in MS," says Power. "We are doing more research investigating this link."

Power has been investigating this specific area for six to seven years.


Contact: Raquel Maurier
University of Alberta Faculty of Medicine & Dentistry

Related biology news :

1. Athens Regional Medical Center Upgrades to Omnicell G4 Platform for Supply and Medication Management
2. Manufacturing microscale medical devices for faster tissue engineering
3. Lung regeneration closer to reality with new discovery by Weill Cornell Medical College researchers
4. 21 Fellows inducted into American College of Medical Informatics
5. Researchers at NYU Langone Medical Center review the microbiome and its possible role in cancers
6. BioCrossroads Invests in Medical Device Company Developing Revolutionary Absorbable Stent
7. Cell biologist Chris A. Kaiser to lead NIHs National Institute of General Medical Sciences
8. Virginia Tech biomedical engineers announce child football helmet study
9. Genomic sequence and comparison of 2 macaques reveal new insights into biomedical research
10. Medical College of Wisconsin researchers show molecule inhibits metastasis
11. Organic medical imaging system to detect disease and track medication
Post Your Comments:
(Date:10/26/2015)... , October 26, 2015 /PRNewswire/ ... --> adds Biometrics ... to 2021 as well as Emerging ... research reports to its collection of ... . --> ...
(Date:10/23/2015)... 23, 2015 Research and Markets ( ... Voice Recognition Biometrics Market 2015-2019" report to their ... The global voice recognition biometrics market to grow ... --> --> The report, ... based on an in-depth market analysis with inputs from ...
(Date:10/22/2015)... JOSE, Calif., Oct. 22, 2015  Synaptics (NASDAQ: SYNA ), ... for its first quarter ended September 30, 2015. ... quarter of fiscal 2016 grew 66 percent over the comparable quarter ... of fiscal 2016 was $23.8 million, or $0.62 per diluted share. ... income for the first quarter of fiscal 2016 grew 39 percent ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... DIEGO , Nov. 24, 2015 Halozyme Therapeutics, Inc. ... Healthcare Conference in New York on Wednesday, ... Helen Torley , president and CEO, will provide a corporate ... New York at 1:00 p.m. ET/10:00 a.m. PT ... and investor relations, will provide a corporate overview. --> ...
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the ... the Toronto Stock Exchange, confirms that as of the ... developments that would cause the recent movements in the ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged in ...
(Date:11/24/2015)... ... ... The Academy of Model Aeronautics (AMA), led by its Executive Council, has officially ... to represent the First–Person View (FPV) racing community. , FPV racing has exploded in ... racing and several new model aviation pilots have joined the community because of their ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna ... announced today that the remaining 11,000 post-share consolidation ... Purchase Warrants (the "Series B Warrants") subject to ... exercised on November 23, 2015, which will result ... After giving effect to the issuance of such ...
Breaking Biology Technology: